AUG 06, 2017 03:50 PM PDT

New Drug Target for Pathological Pain is Identified

WRITTEN BY: Carmen Leitch
2 4 677

Our nation is facing unprecedented challenges because of chronic pain. As pain relievers were made to be more and more powerful, there were unforeseen consequences from medicating so many people with really strong opiates. That is only one reason researchers have long been searching for alternative ways to treat pain, a search that’s becoming a more pressing issue. New work published in PLOS Biology presents a potential new target for the treatment of pain - phosphorylation outside of the cell.

Researchers may have found a new way to treat pain. / Credit: Pixabay

As chemicals send signals in our body to carry out cellular function, one way messages are sent is through small modifications to proteins. One such modification is phosphorylation, in which an enzyme adds a phosphate group to an amino acid residue of a molecule. That alteration can change the shape of the protein, move the protein to another location, allow it to recruit other proteins, and carry out cell processes.

Phosphorylation is related to neuronal activity and pathological pain. There are several types of pain, like that from a burn or that from an impact. Pathological pain is different from other kinds of pain because it results from a dysfunction in neurons. It results in sensations of pain even when no hurtful stimulus is occurring, or a painful state that is maintained long after a painful event.

"Although we have yet to discover the exact mechanism that causes this modification, this finding offers both a target for developing new treatments and a strong new tool for studying synapses in general,” noted Matthew Dalva. He is Professor and Vice Chair in the Department of Neuroscience at The Vickie and Jack Farber Institute for Neuroscience of Sidney Kimmel Medical College, Thomas Jefferson University.

While it’s known that NMDA receptors have a critical role in pathological pain, they also are important to memory and learning; as such they are not good targets for drug interference. The researchers had to find another starting point.

Working with investigators at New York University and the University of Texas at Dallas, the team identified another receptor, ephrin B or EphB2, which gets phosphorylated outside of neurons in response to painful stimuli.

The EphB2 receptor can bind to the NMDA receptor, which modifies the NMDA receptor and pushes it into the synaptic space, a critical junction between nerve cells. The result is an increase in sensitivity to pain. Investigating further, they found by using a chemical that interferes with the EphB2 and NMDA receptor interaction, pain could be blocked.

"Because the protein modification that initiates nerve sensitivity to pain occurs outside of the cell, it offers us an easier target for drug development," Dalva explained. "This is a promising advance in the field of pain management."


Sources: UPI via Thomas Jefferson University, PLOS Biology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 21, 2018
Cell & Molecular Biology
JUN 21, 2018
Are Patterns in Biology Governed by a Turing Theory?
Alan Turing didn't only contribute to computing & mathematics. He also developed a theory about how biological patterns form.
JUN 28, 2018
JUN 28, 2018
Synthetic T Cells the Next Big Thing in Immunotherapy
The highly complex structure and function of human T cells made the creation of synthetic versions of the immune cells difficult, but scientists from Unive
JUL 09, 2018
JUL 09, 2018
More Research With Lab-Grown Organoids
When researching diseases that affect the brain, it's difficult to ethically use human patients. There are experiments that cannot be performed on livi
JUL 21, 2018
Genetics & Genomics
JUL 21, 2018
Designer Cells Sense & Destroy MRSA
Staphylococcus aureus is thought to lead to over 11 million visits to the doctor and the ER every year in the US alone.
JUL 21, 2018
JUL 21, 2018
Artificial Nerves May Transform Prosthetics
Researchers at Stanford made an artificial nerve that could move a cockroach leg.
AUG 11, 2018
AUG 11, 2018
Hit The Sweet Spot - MIT's Image Awards
MIT researchers are trying to engineer a smarter insulin.
Loading Comments...